Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,111 | 64 | 98.7% |
| Education | $14.48 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $382.43 | 23 | $0 (2023) |
| Amarin Pharma Inc. | $364.90 | 22 | $0 (2021) |
| GlaxoSmithKline, LLC. | $69.68 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $51.45 | 4 | $0 (2020) |
| Novo Nordisk Inc | $38.51 | 2 | $0 (2024) |
| Amgen Inc. | $33.31 | 2 | $0 (2021) |
| Horizon Therapeutics plc | $32.57 | 1 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $30.80 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $25.86 | 2 | $0 (2019) |
| Exact Sciences Corporation | $20.85 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.86 | 6 | Novo Nordisk Inc ($38.51) |
| 2023 | $90.56 | 4 | GlaxoSmithKline, LLC. ($55.20) |
| 2022 | $13.19 | 1 | AstraZeneca Pharmaceuticals LP ($13.19) |
| 2021 | $145.81 | 9 | Amarin Pharma Inc. ($59.02) |
| 2020 | $635.78 | 38 | Amarin Pharma Inc. ($305.88) |
| 2019 | $72.91 | 4 | Horizon Therapeutics plc ($32.57) |
| 2018 | $41.99 | 3 | Janssen Pharmaceuticals, Inc ($41.99) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 08/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
| 03/30/2023 | AstraZeneca Pharmaceuticals LP | XIGDUO (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $37.20 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Respiratory | ||||||
| 11/13/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Respiratory | ||||||
| 06/25/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 04/01/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neuroscience | ||||||
| 03/26/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Cardiovascular | ||||||
| 02/20/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Respiratory | ||||||
| 01/28/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular | ||||||
| 01/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular | ||||||
| 01/13/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Neuroscience | ||||||
| 12/28/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Cardiovascular | ||||||
| 11/25/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Respiratory | ||||||
| 11/13/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular | ||||||
| 11/13/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,064 | 1,425 | $296,428 | $55,374 |
| 2022 | 18 | 1,530 | 1,952 | $230,660 | $76,630 |
| 2021 | 17 | 1,435 | 2,107 | $230,591 | $111,205 |
| 2020 | 21 | 1,795 | 2,558 | $255,272 | $115,479 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 409 | $138,038 | $21,285 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 292 | $69,905 | $11,638 | 16.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $64,804 | $10,620 | 16.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 53 | 54 | $4,310 | $4,007 | 93.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 154 | 154 | $7,069 | $2,944 | 41.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 107 | 107 | $5,008 | $2,039 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 58 | $2,662 | $1,825 | 68.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 66 | $2,640 | $609.28 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 42 | 61 | $1,220 | $204.60 | 16.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 18 | 18 | $540.00 | $109.98 | 20.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 18 | 18 | $234.00 | $91.44 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 422 | $82,229 | $22,187 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 247 | 400 | $55,663 | $17,106 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 216 | 216 | $41,009 | $13,548 | 33.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 85 | 86 | $6,440 | $6,034 | 93.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 182 | 182 | $4,725 | $3,444 | 72.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 157 | 159 | $18,077 | $3,115 | 17.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 21 | $6,209 | $2,374 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 89 | 90 | $2,341 | $2,122 | 90.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 17 | $3,550 | $1,479 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,068 | $1,354 | 44.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 31 | 34 | $2,387 | $1,328 | 55.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 41 | 70 | $1,580 | $671.11 | 42.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 12 | 20 | $1,071 | $577.32 | 53.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 57 | 58 | $377.00 | $324.72 | 86.1% |
About Dr. Timothy Gray, D.O
Dr. Timothy Gray, D.O is a Family Medicine healthcare provider based in Forest Grove, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003810441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Gray, D.O has received a total of $1,125 in payments from pharmaceutical and medical device companies, with $124.86 received in 2024. These payments were reported across 65 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,111).
As a Medicare-enrolled provider, Gray has provided services to 5,824 Medicare beneficiaries, totaling 8,042 services with total Medicare billing of $358,688. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Forest Grove, OR
- Active Since 06/13/2005
- Last Updated 11/12/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003810441
Products in Payments
- Vascepa (Drug) $364.90
- SYMBICORT (Drug) $141.94
- FARXIGA (Drug) $108.61
- TRELEGY ELLIPTA (Drug) $69.68
- BREZTRI AEROSPHERE (Drug) $64.75
- BREZTRI (Drug) $52.62
- INVOKANA (Drug) $40.88
- Aimovig (Biological) $33.31
- KRYSTEXXA (Biological) $32.57
- VOQUEZNA (Drug) $30.80
- JANUVIA (Drug) $25.86
- Rybelsus (Drug) $21.50
- Cologuard Collection Kit (Device) $20.85
- ELIQUIS (Drug) $19.19
- PAXLOVID (Drug) $19.11
- Ozempic (Drug) $17.01
- VRAYLAR (Drug) $15.97
- XIGDUO (Drug) $14.51
- XARELTO (Drug) $10.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Forest Grove
Dr. Timothy Gray, D.o, D.O
Family Medicine — Payments: $985.50
Dr. Benjamin Burton, Do, DO
Family Medicine — Payments: $161.62
Hillary Lane, Md, MD
Family Medicine — Payments: $141.59
Roger Reynolds, D.o, D.O
Family Medicine — Payments: $87.74
Emaan Khan, Pa-C, PA-C
Family Medicine — Payments: $15.86
Dr. Sean Steward, Md, MD
Family Medicine